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Artemisia afra Jacq. Ex Willd., Carpobrotus edulis L. and Tulbaghia violacea Harv. were screened for 
activity against Bacillus cereus, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and 
Mycobacterium aurum A+ strain using a two-fold microdilution bioassay. M. aurum is tuberculosis (TB) 
related strain that was used in this study. These plants were selected based on their use by South 
African traditional healers for the treatment of TB and symptoms of the disease. All three plants were 
extracted with water, ethanol and dichloromethane. The extracts of A. afra were found to be active 
against all the tested microorganisms. Only in the instance of A. afra and C. edulis did water extract 
show activity against M. aurum A+ strain. The ethanol extract of C. edulis showed very good activity 
against the Gram-positive bacteria only. Dichloromethane extracts of T. violacea were found to be 
highly active against all the microorganisms, except for K. pneumoniae. 
 





Tuberculosis (TB) remains one of the most prevalent 
causes of death in developing countries, due to a single 
infectious bacterial agent called Mycobacterium tuber-
culosis (WHO, 1998). Currently, one third of the world’s 
population is infected with M. tuberculosis and each year 
there are 2 - 3 million deaths worldwide caused by the 
disease (Zumla et al., 1999). TB is a leading cause of 
death among people with human immunodeficiency virus 
(HIV). Individuals infected with HIV are very susceptible 
to TB and often develop this disease before other 
manifestations of AIDS become apparent (Grange and 
Davey, 1990; Lall and Meyer, 1999). Today, strains of TB 
that are resistant to all major anti-TB drugs have emer-
ged. The emergence of resistance to antimicrobials, 
though is a natural biological occurrence, has become an 
important public health issue in many developing 
countries as the treatment of TB requires the use of more 
expensive drugs for a longer treatment period. There is, 
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which are more effective and withless side effects. 
Medicinal plants are an integral part of South African 
culture. In South Africa, 21st century drug therapy is used 
alongside with traditional African medicines to heal the 
sick. While plants have been used in traditional medicine 
to treat various ailments, scientific analyses of the sup-
posed benefits of many plants is still inadequate espe-
cially in southern Africa. Artemisia afra Jacq. Ex Willd., 
commonly known as ‘Umhlonyane’ in Xhosa, is a shrubby 
perennial herb with leafy and hairy stem. The plant is 
widely used for various medicinal purposes by different 
cultures in different geographical areas. A. afra has been 
traditionally used for respiratory disorders such as 
coughs, colds, whooping cough, bronchitis and asthma. It 
is also used in treating fevers, mumps swelling, pneu-
monia, pimples and skin rashes (Van Wyk and Gericke, 
2000). Carpobrotus edulis L., also referred to as sour fig 
or Hottentot’s fig, is widely utilized as a traditional remedy 
for a wide range of bacterial and fungal infections (Smith 
et al., 1998) including the treatment of eczema, burns, 
wounds, TB, vaginal thrush, toothache and earache (Van 
Wyk et al., 1997). Tulbaghia violacea Harv. is a small 
bulbous herb that grows in rocky grasslands. Its ever-
green leaves exhibit  a  garlic-like  smell  and  have  been  




used in some cultures as a substitute for garlic and chive 
(Kubec et al., 2002). The plant is known by several 
common names including ‘wild garlic’ and ‘society garlic’. 
T. violacea has been traditionally used for the treatment 
of colds, fever, asthma, TB, stomach problems and fits. It 
has also been reported that the Zulus grow T. violacea 
around their homes to repel snakes (Hutchings et al., 
1996; van Wyk and Gericke, 2000).  
Based on the ethnomedical information on these plants, 
they were screened against two Gram-positive bacteria, 
B. cereus and S. aureus, two Gram-negative bacteria, 
Escherichia coli and Klebsiella pneumoniae, and M. 
aurum A+ strain. M. aurum is a sister strain of M. 
tuberculosis which is the causative agent of TB. A study 
undertaken by Chung et al. (1995) has shown that the 
susceptibility of M. aurum closely resembled that of M. 
tuberculosis as compared to other strains of Myco-
bacteria. The other four bacteria were included because 
of their opportunistic properties. Immuno-compromised 
individuals are susceptible to a number of infections 
which are caused by a number of pathogens including 
the bacteria incorporated in this study. In this study, three 
traditionally used medicinal plants, viz., A. afra, C. edulis 
and T. violacea were investigated for their activity against 
five bacteria including M. aurum. 
 
 




The leaves of A. afra were collected from Alice, while C. edulis 
(leaves) and the bulb of T. violacea were collected from Graham-
stown, in the Eastern Cape Province of South Africa (latitudes 
30°00´- 34°15´S and longitudes 22°45´ - 30°15´E). A voucher 
specimen (Buwa 01, 02 and 03) for each plant was prepared and 
deposited in the herbarium of the University of Fort Hare. Each 
plant material was chopped into small pieces, air dried and ground 





Three separate samples of 1 g each were extracted with 10 ml 
water, 100% ethanol and dichloromethane respectively. Extraction 
was performed by shaking in these solvents for 24 h, at room 
temperature. The plant extracts were filtered through Whatman No. 
1 filter paper and evaporated to small fractions under reduced 
pressure using a rotary evaporator. The filtrates were taken to total 
dryness in front of a fan until a constant dry weight of each extract 
was obtained. This was done by weighing plant extracts daily. The 
residues were stored at 10°C until used.  
 
 
Bacterial strains and inoculum preparation 
 
Bacillus cereus, E. coli, K. pneumoniae, and Staphylococcus 
aureus were laboratory isolates obtained from the Department of 
Biochemistry and Microbiology, University of Fort Hare, South 
Africa, while M. aurum A+ strain was obtained from the Micro-
biology Laboratory, Division of Pharmacology, University of Cape 
Town. B. cereus, E. coli, K. pneumoniae and S. aureus were 





culturing a single colony in 2 ml nutrient broth for 24 h, after which 
the optical density (OD) at 600 nm for each liquid culture was 
determined. The saturated bacterial culture was then diluted with 
nutrient broth (1 ml bacteria: 99 ml broth), to make certain that the 




Preparation of M. aurum A+ stocks 
 
M. aurum A+ was maintained in Middlebrook 7H9 broth containing 
10% OADC (oleic acid + albumin + dextrose + catalase). Inoculum 
was prepared by transferring the stock bacterial culture to supple-
mented 7H9 broth (Middlebrook 7H9 + 10% OADC) and grown for 
72 h on a shaker. Two (5 ml) supplemented 7H9 broths were inocu-
lated by the bacterial culture and grown for 72 h. Twenty percent 
sterile glycerol was added to each culture and 500 µl aliquots were 
made into sterile Eppendorf tubes. These stocks were named G1 
stocks and were stored at -30°C. A single G1 stock was used to 
inoculate supplemented Middlebrook 7H10 agar (7H10 + 10% 
OADC) plates and incubated at 37°C for four days or until growth 
was observed. From this culture a single colony was used to 
inoculate 5 ml supplemented 7H9 broth. This was grown on a 





For the screening of the extracts against B. cereus, E. coli, K. 
pneumoniae and S. aureus, the microplate method of Eloff (1998) 
was used. Residues of plant extracts were redissolved with the 
extracting solvents at a concentration of 50 mg/ml. Dichloro-
methane extracts were redissolved in 25% ethanol. All extracts 
were initially tested at 12.5 mg/ml in 96-well microplates and serially 
diluted two-fold to 0.098 mg/ml, after which 100 µl bacterial culture 
were added to each well. Streptomycin (100 µg/ml) served as a 
positive control for each bacterium, whereas a solvent used to 
dissolve plant extracts was included as a negative control and 
bacteria free wells were included as blank controls. The microplates 
were covered and incubated for 24 h at 37°C. As an indicator of 
bacterial growth, 40 µl p-iodonitrotetrazolium violet (INT) (0.2 
mg/ml) dissolved in water were added to the wells and incubated at 
37°C for 30 min. MIC values were recorded as the lowest concen-
tration of the extract that completely inhibited bacterial growth, that 
is a clear well. All extracts were tested in triplicates. 
The broth microdilution method (Swenson et al., 1982) was used 
to determine the MIC of M. aurum A+ of the investigated plant 
extracts. The aqueous extract residues were redissolved in water 
and other extract residues were dissolved in dimethyl sulfoxide 
(DMSO). All extracts were dissolved to a concentration of 100 
mg/ml. One hundred microliter of the supplemented 7H9 broth was 
added to all the wells of microtitre plates. All extracts were tested at 
a concentration of 25 mg/ml and serially diluted to 0.195 mg/ml. 
The optical density of the 72 h broth culture was determined and 
adjusted at 550 nm. One hundred microliter of the diluted culture 
was added to every well of the microtitre plate. The controls inclu-
ded the solvent used to dissolve plant extracts, Middlebrook 7H9 
broth alone, and the antibiotic streptomycin (1.56 mg/ml) as a 
positive control. The plates were covered and incubated at 37°C for 
72 h. After incubation, 40 µl of 0.4 mg/ml solution of INT was added 
to each well of the plate. The plates were covered and incubated for 





The leaves of A. afra showed the best MIC values  for  all 

















































































Streptomycin (µg/ml)  3.125 0.780 0.780 0.390 0.750 
 




the tested extracts, including water (Table 1). The MIC 
values in aqueous extracts were high, especially against 
E. coli, a Gram-negative bacterium, followed by K. pneu-
moniae and S. aureus. It is worth noting that only in the 
case of A. afra and C. edulis did water extract show 
activity against M. aurum A+. This is interesting as drugs 
used by traditional healers are mostly prepared with 
water. The antimycobacterial activity for C. edulis was 
weak as compared to that of A. afra. A. afra has been 
reported for its use in traditional medicine to treat fever, 
colds, pneumonia and pulmonary TB. The ethanolic and 
dichloromethane extracts exhibited very good activity 
against all the tested microorganisms, with concen-
trations ranging from 0.163 to 0.098 mg/ml. Concerning 
M. aurum A+, the ethanolic and dichloromethane extracts 
had weak activity. 
The ethanolic extract of C. edulis displayed strong activity 
against Gram-positive bacteria whereas weak activity 
was detected against E. coli and K. pneumoniae which 
are Gram-negative bacteria. The ethanolic extract dis-
played the lowest antimycobacterial activity as compared 
to both water and dichloromethane extracts.  
T. violacea extracts showed the best MIC values for the 
dichloromethane extracts against all the tested bacteria 
excluding K. pneumoniae. The dichloromethane extract 
was exceptionally active against M. aurum. The aqueous 






TB is the leading killer of youths, women, and AIDS 
patients world wide (Mann et al., 2008). Although people 
with HIV/AIDS are dangerously susceptible to a number 
of opportunistic infections, TB is without doubt, the main 
cause of death. There is, therefore, the challenge to fight 
multidrug-resistant (MDR) TB. People infected with HIV 
and living with AIDS are at great risk for developing MDR 
TB. The search for new anti-tuberculosis drugs has 
become more important due to the above reasons and 
others such as shortage and expensive nature of TB 
drugs. Traditional medicine is a readily available alterna-
tive in the search for new antimycobacterial compounds. 
The plants screened in this study are used in traditional 
medicinal practices for the treatment of various diseases 
including TB. 
The results obtained from this study justify the 
traditional use of A. afra, C. edulis and T. violacea for the 
treatment of TB or its symptoms. They also substantiate 
their potentials as sources of leads in the development of 
antituberculosis agents. However, the aqueous extracts 
of C. edulis and T. violacea displayed weak or no activity 
against M. aurum, even at concentration as high as 25 
mg/ml. This may be due to the complex lipoglycan calyx 
on the cell surface which provides a significant physical 
barrier to intracellular acting compound (Ballell et al., 
2005). Lack of penetration is thought to be a reason why 
many antibiotics show no activity against M. tuberculosis 
(Gao et al., 2003). Cell wall biosynthesis is believed to be 
a key target for antimycobacterial chemotherapy (Eldeen 
and van Staden, 2007).  
Although water is the most commonly solvent used by 
traditional healers to extract the active compounds due to 
its availability, antimycobacterial screening of T. violacea 
generally resulted in higher inhibitory activity from 
dichloromethane extract as compared to water and 
ethanol. This suggests that water is not the most effective 
solvent at extracting the active compounds from the 
plant. However, considering the fact that the dosage pre-
scribed by the traditional healers is usually very high, for 
instance three to four cupfuls per day for adult, water can 
still be considered as an appropriate extracting solvent 
for traditional remedies (Shale et al., 1999). Conversely, 
negative results do not mean absence of bioactive 
constituents nor that the plant  is  inactive,  plant  extracts 




may act in other ways by stimulating the immune system 
of the patient, or by creating internal conditions that are 
unfavourable for the multiplication of the microorganism. 
Newton et al. (2002) reported that there were a number 
of plants, supposedly used in traditional medicine to treat 
TB, which did not demonstrate any antimycobacterial 
activity against M. aurum and M. smegmatis. The author 
suggested that the plants may be used to treat the 
symptoms of the disease rather than actually cure the 
disease itself. Although these plants are traditionally used 
for treating TB and other respiratory diseases, it is 
possible that these plant extracts are effective against 
ailments such as bronchitis, cough and asthma caused 
by agents other than Mycobacteria. Screening directly 
against TB agent is unsafe because of the highly 
infectious nature of the pathogen and is time consuming 
as the organism is relatively slow growing (Bloom, 1994). 
In the current study, the extracts of A. afra leaves 
showed the best activities. A number of studies have 
revealed that the essential oil of leaves of A. afra contain 
1,8-cineole, -thujone, -thujone, camphor and borneol, 
which are known to exhibit antimicrobial properties 
(Graven et al., 1992; van Wyk and Gericke, 2000). The 
oil may be responsible for some of the activities of this 
plant. 1.8-cineole has been reported to exhibit significant 
antimicrobial activity against certain Gram-negative and 
Gram-positive bacteria including E. coli, B. subtilis, S. 
aureus and Mycobacterium phlei (Pooter et al., 1995). 
Aqueous extracts of A. afra also contain flavonoids which 
have been reported to possess antimicrobial, anti-inflam-
matory, anti-oxidant and anti-mutagenic properties (Rice-
Evans, 1997; Tang et al., 2000; van Wyk and Gericke, 
2000; Miura et al., 2003; Sadik et al., 2003; Remberg et 
al., 2004). In a study done by McGaw et al. (2000), the 
ethanolic extract of A. afra exhibited some activity 
whereas T. violacea had no activity.Very good activity 
was also observed with ethanol extract of C. edulis 
leaves against B. cereus, S. aureus and M. aurum. In a 
study undertaken by Van der Watt and Pretorius  (2001) 
five active flavonoids isolated from C. edulis were purified 
and identified as rutin, neohesperidin, hyperoside, cacti-
chin and ferulic acid. These flavonoids showed activity 
against B. subtilis, S. aureus, S. epidermidis, Strepto-
coccus pneumoniae, Moraxella catarrhalis and Pseudo-
monas aeruginosa. 
 A study undertaken by Martins et al. (2005) have 
shown that the methanol extract of C. edulis, inactive 
against the methicillin-resistant S. aureus or the multi-
drug-resistant M. tuberculosis, does inhibit the growth of 
these two bacteria once they are phagocytosed by mono-
cyte derived human macrophages. Our results correlate 
with the antimicrobial effects observed with the traditional 
uses of C. edulis reported by Van Wyk et al. (1997) and 
Martins et al. (2005) and suggest that this plant may 
serve as a source of new antimicrobial agents that are 
effective against problematic drug-resistant infections., C. 





in the Eastern Cape Province of South Africa, exhibited 
significant antibacterial activities which may explain and 
justify the usage of these plants by traditional healers. It 
has also highlighted the importance of assessing the 
herbal remedies used by traditional practitioners. It has 
shown that some plant extracts, particularly T. violaceae 
water extract, may not contain compounds which inhibit 
the growth of or kill M. aurum but it is possible that the 
may have stimulant effects on the immune system. 
However, no compounds from extracts of these plant 
species with antimycobacterial activity have been re-
ported so far. Further investigation on seasonal variation 
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